Cargando…

SARS-CoV-2 main protease Nsp5 cleaves and inactivates human tRNA methyltransferase TRMT1

Detalles Bibliográficos
Autores principales:	Lu, Jia-Li, Zhou, Xiao-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399916/ https://www.ncbi.nlm.nih.gov/pubmed/37073102 http://dx.doi.org/10.1093/jmcb/mjad024

Ejemplares similares

Recognition and Cleavage of Human tRNA Methyltransferase TRMT1 by the SARS-CoV-2 Main Protease
por: D′Oliviera, Angel, et al.
Publicado: (2023)

Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease
por: Zhang, Kejia, et al.
Publicado: (2023)

Functional characterization of the human tRNA methyltransferases TRMT10A and TRMT10B
por: Vilardo, Elisa, et al.
Publicado: (2020)

Distinct substrate specificities of the human tRNA methyltransferases TRMT10A and TRMT10B
por: Howell, Nathan W., et al.
Publicado: (2019)

Structure of SARS-CoV-2 main protease in the apo state
por: Zhou, Xuelan, et al.
Publicado: (2020)

Mitochondrial 16S rRNA Is Methylated by tRNA Methyltransferase TRMT61B in All Vertebrates
por: Bar-Yaacov, Dan, et al.
Publicado: (2016)

A dual role of human tRNA methyltransferase hTrmt13 in regulating translation and transcription
por: Li, Hao, et al.
Publicado: (2021)

Expanded tRNA methyltransferase family member TRMT9B regulates synaptic growth and function
por: Hogan, Caley A, et al.
Publicado: (2023)

Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase
por: Benoni, Roberto, et al.
Publicado: (2021)

Correction: Mitochondrial 16S rRNA Is Methylated by tRNA Methyltransferase TRMT61B in All Vertebrates
por: Bar-Yaacov, Dan, et al.
Publicado: (2017)

tRNA Methyltransferase Homolog Gene TRMT10A Mutation in Young Onset Diabetes and Primary Microcephaly in Humans
por: Igoillo-Esteve, Mariana, et al.
Publicado: (2013)

NMR assignment of the protein nsp3a from SARS-CoV
por: Serrano, P., et al.
Publicado: (2006)

SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense
por: Ju, Xiaohui, et al.
Publicado: (2023)

Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2
por: Azad, Gajendra Kumar
Publicado: (2020)

Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease
por: Lipiński, Piotr F.J., et al.
Publicado: (2021)

THUMPD3–TRMT112 is a m(2)G methyltransferase working on a broad range of tRNA substrates
por: Yang, Wen-Qing, et al.
Publicado: (2021)

tRNA methyltransferase homologue gene TRMT10A mutation in young adult‐onset diabetes with intellectual disability, microcephaly and epilepsy
por: Yew, T. W., et al.
Publicado: (2016)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
por: Milligan, Jennifer C., et al.
Publicado: (2021)

Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
por: Bobrovs, Raitis, et al.
Publicado: (2021)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

Human TRMT2A methylates tRNA and contributes to translation fidelity
por: Witzenberger, Monika, et al.
Publicado: (2023)

In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex
por: Liang, Julia, et al.
Publicado: (2021)

Virtual screening of molecular databases for potential inhibitors of the NSP16/NSP10 methyltransferase from SARS-CoV-2
por: Gomes, João Pedro Agra, et al.
Publicado: (2022)

Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2
por: Balieiro, Alessandra M., et al.
Publicado: (2022)

Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies
por: Yashvardhini, Niti, et al.
Publicado: (2022)

Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies
por: Yashvardhini, Niti, et al.
Publicado: (2022)

Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling
por: Feng, Kuan, et al.
Publicado: (2021)

tRNA methyltransferase 10 homologue A (TRMT10A) mutation in a Chinese patient with diabetes, insulin resistance, intellectual deficiency and microcephaly
por: Lin, Hu, et al.
Publicado: (2020)

Identification and Inhibition of the Druggable Allosteric Site of SARS-CoV-2 NSP10/NSP16 Methyltransferase through Computational Approaches
por: Faisal, Shah, et al.
Publicado: (2022)

Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors
por: Štefek, Milan, et al.
Publicado: (2023)

The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
por: Wenzel, Jan, et al.
Publicado: (2021)

Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease
por: Yan, Haohao, et al.
Publicado: (2023)

The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates
por: Yang, Jiaxin, et al.
Publicado: (2023)

Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis
por: Saeed, Aamir, et al.
Publicado: (2022)

Vitamin D deficiency and inactivated SARS-CoV-2 vaccines
por: Wu, Chia-Chao, et al.
Publicado: (2021)

Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease
por: Behnam, Mira A. M., et al.
Publicado: (2021)

High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease
por: Li, Yan, et al.
Publicado: (2021)

Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir
por: Bai, Yu, et al.
Publicado: (2021)

The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
por: Liang, Weifeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hj4im2osdm4bb4skccnpaergt9